Donatella Treppiedi

Dopamine receptor type 2 (<scp>DRD2</scp>) and somatostatin receptor type 2 (<scp>SSTR2</scp>) agonists are effective in inhibiting proliferation of progenitor/stem‐like cells isolated from nonfunctioning pituitary tumors

Erika Peverelli, Elena Giardino, Donatella Treppiedi et al. · International Journal of Cancer · 2017 · 60 citations · Full text

Medicine, Endocrinology, Oncology +17

Filamin A (FLNA) Plays an Essential Role in Somatostatin Receptor 2 (SST2) Signaling and Stabilization After Agonist Stimulation in Human and Rat Somatotroph Tumor Cells

Erika Peverelli, Elena Giardino, Donatella Treppiedi et al. · Endocrinology · 2014 · 51 citations · Full text

Life Sciences, Endocrinology, Pharmacology +17

cAMP/PKA-induced filamin A (FLNA) phosphorylation inhibits SST2 signal transduction in GH-secreting pituitary tumor cells

Erika Peverelli, Elena Giardino, Federica Mangili et al. · Cancer Letters · 2018 · 34 citations

Life Sciences, Biochemistry, Endocrinology +15

Dopamine receptor type 2 (DRD2) inhibits migration and invasion of human tumorous pituitary cells through ROCK-mediated cofilin inactivation

Erika Peverelli, Elena Giardino, Donatella Treppiedi et al. · Cancer Letters · 2016 · 33 citations

Medicine, Cancer Biology, Oncology +16

A novel pathway activated by somatostatin receptor type 2 (SST2): Inhibition of pituitary tumor cell migration and invasion through cytoskeleton protein recruitment

Erika Peverelli, Elena Giardino, Donatella Treppiedi et al. · International Journal of Cancer · 2017 · 29 citations · Full text

Medicine, Endocrinology, Pharmacology +17